Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Korean Hypertension Cohort study: design and baseline characteristics.
Lee HY, Lee JY, Shin HG, Cho SH, Park KI, Oh GC, Lee SP, Kim H, Lee HS, Kim KI, Kang SH, Lee JH, Jang SY, Lee JH, Kim KH, Cho JY, Park JH, Jang J, Park SK, Bak JK. Lee HY, et al. Among authors: lee hs, lee sp, lee jy, lee jh. Korean J Intern Med. 2021 Sep;36(5):1115-1125. doi: 10.3904/kjim.2020.551. Epub 2021 Jul 22. Korean J Intern Med. 2021. PMID: 34289586 Free PMC article.
Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease.
Lee SP, Suh JW, Park KW, Lee HY, Kang HJ, Koo BK, Chae IH, Choi DJ, Rha SW, Bae JW, Cho MC, Kwon TG, Bae JH, Kim HS; CILON-T investigators. Lee SP, et al. Among authors: lee hy. Trials. 2010 Aug 24;11:87. doi: 10.1186/1745-6215-11-87. Trials. 2010. PMID: 20735821 Free PMC article. Clinical Trial.
Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial.
Park KW, Park JJ, Lee SP, Oh IY, Suh JW, Yang HM, Lee HY, Kang HJ, Cho YS, Koo BK, Youn TJ, Chae IH, Choi DJ, Oh BH, Park YB, Kim HS. Park KW, et al. Among authors: lee sp, lee hy. Heart. 2011 Apr;97(8):641-7. doi: 10.1136/hrt.2010.216499. Epub 2011 Feb 22. Heart. 2011. PMID: 21345843 Clinical Trial.
Efficacy of predicting thrombotic events with combination of dual point-of-care testing (POCT) after drug-eluting stent implantation for coronary heart disease: results from the CILON-T randomized trial POCT substudy.
Lee SP, Park KW, Shin DH, Lee HY, Kang HJ, Koo BK, Suh JW, Youn TJ, Choi DJ, Chae IH, Kim HS. Lee SP, et al. Among authors: lee hy. J Atheroscler Thromb. 2011;18(10):914-23. doi: 10.5551/jat.9290. Epub 2011 Jul 26. J Atheroscler Thromb. 2011. PMID: 21791883 Free article. Clinical Trial.
The 'Harmonizing Optimal Strategy for Treatment of coronary artery stenosis - sAfety & effectiveneSS of drug-elUting stents & antiplatelet REgimen' (HOST-ASSURE) trial: study protocol for a randomized controlled trial.
Park KW, Park BE, Kang SH, Park JJ, Lee SP, Cha KS, Rhew JY, Jeon HK, Shin ES, Oh JH, Jeong MH, Kim S, Hwang KK, Yoon JH, Lee SY, Park TH, Moon KW, Kwon HM, Chae IH, Kim HS; HOST investigators. Park KW, et al. Among authors: lee sy, lee sp. Trials. 2012 Mar 31;13:29. doi: 10.1186/1745-6215-13-29. Trials. 2012. PMID: 22463698 Free PMC article. Clinical Trial.
Assessment of clinical, electrocardiographic, and physiological relevance of diagonal branch in left anterior descending coronary artery bifurcation lesions.
Koo BK, Lee SP, Lee JH, Park KW, Suh JW, Cho YS, Chung WY, Doh JH, Nam CW, Yu CW, Lee BK, Vassilev D, Gil R, Lim HS, Tahk SJ, Kim HS. Koo BK, et al. Among authors: lee bk, lee sp, lee jh. JACC Cardiovasc Interv. 2012 Nov;5(11):1126-32. doi: 10.1016/j.jcin.2012.05.018. JACC Cardiovasc Interv. 2012. PMID: 23174636 Free article. Clinical Trial.
1,132 results